BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33341391)

  • 1. Diabetic Retinopathy: Important Biochemical Alterations and the Main Treatment Strategies.
    ValdezGuerrero AS; Quintana-Pérez JC; Arellano-Mendoza MG; Castañeda-Ibarra FJ; Tamay-Cach F; Alemán-González-Duhart D
    Can J Diabetes; 2021 Aug; 45(6):504-511. PubMed ID: 33341391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose transport, transporters and metabolism in diabetic retinopathy.
    Zhang C; Gu L; Xie H; Liu Y; Huang P; Zhang J; Luo D; Zhang J
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166995. PubMed ID: 38142757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy.
    Roy S; Kern TS; Song B; Stuebe C
    Am J Pathol; 2017 Jan; 187(1):9-19. PubMed ID: 27846381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
    Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
    Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and oxidative stress in the causation of diabetic retinopathy.
    Arden GB; Sivaprasad S
    Curr Diabetes Rev; 2011 Sep; 7(5):291-304. PubMed ID: 21916837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
    Holoman NC; Aiello JJ; Trobenter TD; Tarchick MJ; Kozlowski MR; Makowski ER; De Vivo DC; Singh C; Sears JE; Samuels IS
    J Neurosci; 2021 Apr; 41(14):3275-3299. PubMed ID: 33622781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perturbed Biochemical Pathways and Associated Oxidative Stress Lead to Vascular Dysfunctions in Diabetic Retinopathy.
    Mahajan N; Arora P; Sandhir R
    Oxid Med Cell Longev; 2019; 2019():8458472. PubMed ID: 30962865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic retinopathy: pathogenesis and therapeutic implications].
    Pelikánová T
    Vnitr Lek; 2016; 62(7-8):620-8. PubMed ID: 27627088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of human C-reactive protein in diabetic retinopathy.
    Qiu F; Ma X; Shin YH; Chen J; Chen Q; Zhou K; Wu W; Liang W; Wu Y; Song Q; Ma JX
    Clin Sci (Lond); 2020 Jul; 134(13):1613-1629. PubMed ID: 32602547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets.
    Safi SZ; Qvist R; Kumar S; Batumalaie K; Ismail IS
    Biomed Res Int; 2014; 2014():801269. PubMed ID: 25105142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.
    Kang Q; Yang C
    Redox Biol; 2020 Oct; 37():101799. PubMed ID: 33248932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.
    Dehdashtian E; Mehrzadi S; Yousefi B; Hosseinzadeh A; Reiter RJ; Safa M; Ghaznavi H; Naseripour M
    Life Sci; 2018 Jan; 193():20-33. PubMed ID: 29203148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Madsen-Bouterse SA; Kowluru RA
    Rev Endocr Metab Disord; 2008 Dec; 9(4):315-27. PubMed ID: 18654858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of oxidative stress in progression of diabetic retinopathy.
    Behl T; Kaur I; Kotwani A
    Surv Ophthalmol; 2016; 61(2):187-96. PubMed ID: 26074354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the treatment of diabetic retinopathy.
    Wilkinson-Berka JL; Miller AG
    ScientificWorldJournal; 2008 Feb; 8():98-120. PubMed ID: 18264628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A correlation between oxidative stress and diabetic retinopathy: An updated review.
    Hussain A; Ashique S; Afzal O; Altamimi MA; Malik A; Kumar S; Garg A; Sharma N; Farid A; Khan T; Altamimi ASA
    Exp Eye Res; 2023 Nov; 236():109650. PubMed ID: 37734426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
    Wan TT; Li XF; Sun YM; Li YB; Su Y
    Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen delivery, consumption, and conversion to reactive oxygen species in experimental models of diabetic retinopathy.
    Eshaq RS; Wright WS; Harris NR
    Redox Biol; 2014; 2():661-6. PubMed ID: 24936440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for and managing diabetic retinopathy: current approaches.
    Bloomgarden ZT
    Am J Health Syst Pharm; 2007 Sep; 64(17 Suppl 12):S8-14. PubMed ID: 17720893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.